“DASH provides central laboratory-quality results at the point of care.” “To help control the spread of this contagious infection, the development of rapid diagnostic testing is essential,” said Northwestern’s David Kelso, co-founder, president and CEO of Minute Molecular.

To develop the rapid PCR test, the researchers are using Minute Molecular’s DASH Analyzer, a compact, portable system that provides easy-to-read results in approximately 15 minutes. The team currently has a working prototype of the monkeypox test, with plans to submit an EUA application to the FDA early next year. Infectious disease specialists at Northwestern University Feinberg School of Medicine will then lead clinical testing. Northwestern and Minute Molecular are collaborating to develop the swab-based test. Now, the team behind this revolutionary test is adapting its platform to detect monkeypox.

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 - developed by Northwestern University spinoff company Minute Molecular Diagnostics - received emergency use authorization (EUA) status from the U.S.

Zoom care rapid covid test